Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5731
Source ID: NCT00503152
Associated Drug: Benazepril
Title: Preventing Microalbuminuria in Type 2 Diabetes
Acronym: VARIETY
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes
Interventions: DRUG: Benazepril|DRUG: Valsartan|DRUG: Benazepril/Valsartan
Outcome Measures: Primary: Development of persistent microalbuminuria (i.e. urinary albumin excretion rate >20 µg/min in at least 2 of 3 consecutive overnight urine collections confirmed in two consecutive visits). Whenever a patient will be found to have 2 of 3 collections in the, 2 times a year | Secondary: Regression to low-normal albuminuria (i.e. urinary albumin excretion rate <7 µg/min in at least 2 of 3 consecutive overnight urine collections confirmed in two consecutive visits); Albuminuria (considered as a continuous variable); Serum creatinine (v, 2 times a year
Sponsor/Collaborators: Sponsor: Mario Negri Institute for Pharmacological Research | Collaborators: Agenzia Italiana del Farmaco
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 612
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2007-05
Completion Date: 2016-09
Results First Posted:
Last Update Posted: 2019-09-06
Locations: Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" - Diabetologic Ambulatory of Ponte San Pietro, Ponte San Pietro, Bergamo, Italy|Clinical Research Center for Rare Diseases "Aldo e Cele Daccò", Ranica, Bergamo, Italy|Hospital "Azienda Ospedaliera di Treviglio e Caravaggio" Unit of Diabetology and Metabolic Diseases, Romano di Lombardia, Bergamo, Italy|Hospital "Bolognini", Seriate, Bergamo, Italy|Hospital "Azienda Ospedaliera di Treviglio-Caravaggio"Unit of Diabetology and Metabolic Diseases, Treviglio, Bergamo, Italy|Hospital "Casa Sollievo della Sofferenza" - Division of Endocrinology, San Giovanni Rotondo, Foggia, Italy|Hospital "Azienda Ospedaliera Ospedali Riuniti di Bergamo" - Unit of Diabetology, Bergamo, Italy|IRCCS San Raffaele - Unit of General Medicine, Milano, Italy|Azienda USL 2, Olbia, Italy
URL: https://clinicaltrials.gov/show/NCT00503152